IntelliCell BioSciences Inc., of New York, appointed Robert Sexauer executive vice president and Sarah Young director of quality assurance...Northwest Biotherapeutics, of Bethesda, Md., added Navid Malik and Jerry Jasinowski to its board

AcelRx Pharmaceuticals Inc., of Redwood City, Calif., named Kim Gaumer vice president, regulatory affairs and quality assurance...Array BioPharma Inc., of Boulder, Colo., appointed Howard Holden vice president of regulatory affairs and quality assurance

Sangart Inc., of San Diego, promoted Frank Booth to chief medical officer, added Mary Rose Keller as vice president of clinical operations and named Carmen Betancourt-Riche vice president of regulatory affairs and quality assurance...Sirona also appointed Sean Cunliffe chief business officer and board member

NexImmune Inc., of Gaithersburg, Md., appointed Kenneth Carter CEO and named Jonathan Schneck chairman of the clinical and scientific advisory board...Pernix Therapeutics Holdings Inc., of The Woodlands, Texas, appointed David Becker chief financial officer, Charles "Chuck" Hrushka vice president of sales and marketing and Leslie White director of regulatory affairs and quality assurance

NexImmune Inc., of Gaithersburg, Md., appointed Kenneth Carter CEO and named Jonathan Schneck chairman of the clinical and scientific advisory board...Pernix Therapeutics Holdings Inc., of The Woodlands, Texas, appointed David Becker chief financial officer, Charles "Chuck" Hrushka vice president of sales and marketing and Leslie White director of regulatory affairs and quality assurance

Concert Pharmaceuticals Inc., of Lexington, Mass., appointed Mark Roessel vice president of regulatory affairs and quality assurance and named LuAnn Sabounjian vice president of clinical operations

OncoMethylome Sciences SA, of Durham, N.C., appointed Melissa A. Thompson vice president of regulatory affairs and quality assurance and named Christopher (Chris) Thibodeau vice president of commercial operations

Ablexis LLC, of San Francisco, appointed Scott Greer chairman and named Richard Hoffman chief business officer...Bioheart Inc., of Sunrise, Fla., appointed Mike Tomas president, CEO and board member, replacing Karl Groth, who will retain his position as chairman...MonoSol Rx, of Warren, N.J., appointed Mary Ellen Norvitch vice president, regulatory affairs/clinical affairs/quality assurance and Eric Dadey senior vice president of pharmaceutical development

Novavax Inc., of Rockville, Md., appointed John W. Madsen head of process and manufacturing operations and named Steven Pincus head of analytical and quality operations...Probiodrug AG, of Halle, Germany, appointed Claus Braestrup chairman and named Lennart Mucke to its scientific advisory board

operations, Karen Hodgkin head of clinical development and Tina Crombie head of business administration...Seaside Therapeutics LLC, of Cambridge, Mass., appointed Tanya N. Lewis vice president of regulatory affairs and quality assurance

DBV Technologies, of Paris, added Gideon Lack and Philippe Eigenmann to its scientific advisory board...The firm also named John Purpura executive vice president for regulatory affairs and quality assurance, effective Nov. 16

DBV Technologies, of Paris, added Gideon Lack and Philippe Eigenmann to its scientific advisory board...The firm also named John Purpura executive vice president for regulatory affairs and quality assurance, effective Nov. 16

Pharmalink AB, of Stockholm, Sweden, added Anders Wiklund, Jens Christensen and Lennart Hansson to its board...Proteolix Inc., of South San Francisco, added Craig Parker as senior vice president of finance and corporate development and chief financial officer, Michael Kauffman as chief medical officer and Albert Krausas vice president of regulatory affairs and quality assurance

Regado Biosciences Inc., of Basking Ridge, N.J., appointed Alexander R. Giaquinto senior vice president of regulatory affairs and quality assurance...Thomas Hecht was appointed chairman, and Michael Motschmann will join the board

UCB SA, of Brussels, Belgium, appointed Michele Antonelli executive vice president of technical operations and quality assurance and named Mark McDade executive vice president of global operations

Cytochroma, of Markham, Ontario, appointed Steven I. Engel vice president of regulatory affairs and quality assurance...It formed its scientific advisory board with the appointments of Dennis Brown, Xandra Breakefield and Richard L. Edelson, and also appointed Johan Skog director of genetics research

Arcxis Biotechnologies, of Pleasanton, Calif., named Christine Meda president and CEO...Cadence Pharmaceuticals Inc., of San Diego, appointed Todd Rich to its board and named Malcolm Lloyd-Smith senior vice president of regulatory affairs and quality assurance

David Mitchell senior director of regulatory affairs and quality assurance...Angeline Shashlo senior vice president of regulatory affairs and quality assurance

and Timothy Maines vice president of corporate quality assurance